Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Oncotarget|December 31, 2015
The drug target genes show higher evolutionary conservation than non-target genesWenhua Lv, Yongdeng Xu, Yiying Guo, et al.
Resuscitation|January 31, 2026
Large-scale plasma proteomic analysis identifies pathophysiological mechanisms and predictive biomarkers for cardiac arrestNing Wang, Yan Guo, Songlin Lu, et al.
Proteomics|January 10, 2024
Effects of genetic variation on the structure of RNA and proteinJingxuan Kang, Siyu Wei, Zhe Jia, et al.
Genes & Diseases|October 10, 2025
The hidden Markov model and its applications in bioinformatics analysisYingnan Ma, Haiyan Chen, Jingxuan Kang, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|June 4, 2026
A large-scale plasma proteomic study reveals the preclinical evolution and potential biomarkers for coronary atherosclerosisChang Wang, Chi Yan, Qinduo Ren, et al.
Nucleic Acids Research|October 16, 2022
RABC: Rheumatoid Arthritis Bioinformatics CenterHaiyan Chen, Jing Xu, Siyu Wei, et al.
Proteomics|March 24, 2024
A review of disease risk prediction methods and applications in the omics eraChen Sun, Xiangshu Cheng, Jing Xu, et al.
Eclinicalmedicine|January 27, 2025
Global, regional, national burden of asthma from 1990 to 2021, with projections of incidence to 2050: a systematic analysis of the global burden of disease study 2021Linna Yuan, Junxian Tao, Jiacheng Wang, et al.
Expert Review of Anticancer Therapy|September 1, 2025
Burden trends and risk factors for prostate cancer from 1990 to 2021: a systematic analysis of the Global Burden of Disease Study 2021Yuan Xu, Ruilin Li, Ning Wang, et al.
Biomarker Research|March 25, 2025
Global, regional and national burden of rheumatoid arthritis from 1990 to 2021, with projections of incidence to 2050: a systematic and comprehensive analysis of the Global Burden of Disease study 2021Yingnan Ma, Haiyan Chen, Wenhua Lv, et al.
Pageof 5